Literature DB >> 25617415

ASSIGN: context-specific genomic profiling of multiple heterogeneous biological pathways.

Ying Shen1, Mumtahena Rahman1, Stephen R Piccolo2, Daniel Gusenleitner1, Nader N El-Chaar1, Luis Cheng1, Stefano Monti1, Andrea H Bild2, W Evan Johnson2.   

Abstract

MOTIVATION: Although gene-expression signature-based biomarkers are often developed for clinical diagnosis, many promising signatures fail to replicate during validation. One major challenge is that biological samples used to generate and validate the signature are often from heterogeneous biological contexts-controlled or in vitro samples may be used to generate the signature, but patient samples may be used for validation. In addition, systematic technical biases from multiple genome-profiling platforms often mask true biological variation. Addressing such challenges will enable us to better elucidate disease mechanisms and provide improved guidance for personalized therapeutics.
RESULTS: Here, we present a pathway profiling toolkit, Adaptive Signature Selection and InteGratioN (ASSIGN), which enables robust and context-specific pathway analyses by efficiently capturing pathway activity in heterogeneous sets of samples and across profiling technologies. The ASSIGN framework is based on a flexible Bayesian factor analysis approach that allows for simultaneous profiling of multiple correlated pathways and for the adaptation of pathway signatures into specific disease. We demonstrate the robustness and versatility of ASSIGN in estimating pathway activity in simulated data, cell lines perturbed pathways and in primary tissues samples including The Cancer Genome Atlas breast carcinoma samples and liver samples exposed to genotoxic carcinogens.
AVAILABILITY AND IMPLEMENTATION: Software for our approach is available for download at: http://www.bioconductor.org/packages/release/bioc/html/ASSIGN.html and https://github.com/wevanjohnson/ASSIGN.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2015        PMID: 25617415      PMCID: PMC4443674          DOI: 10.1093/bioinformatics/btv031

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  35 in total

Review 1.  The Ames Salmonella/microsome mutagenicity assay.

Authors:  K Mortelmans; E Zeiger
Journal:  Mutat Res       Date:  2000-11-20       Impact factor: 2.433

2.  Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action.

Authors:  Brigitte Ganter; Stuart Tugendreich; Cecelia I Pearson; Eser Ayanoglu; Susanne Baumhueter; Keith A Bostian; Lindsay Brady; Leslie J Browne; John T Calvin; Gwo-Jen Day; Naiomi Breckenridge; Shane Dunlea; Barrett P Eynon; L Mike Furness; Joe Ferng; Mark R Fielden; Susan Y Fujimoto; Li Gong; Christopher Hu; Radha Idury; Michael S B Judo; Kyle L Kolaja; May D Lee; Christopher McSorley; James M Minor; Ramesh V Nair; Georges Natsoulis; Peter Nguyen; Simone M Nicholson; Hang Pham; Alan H Roter; Dongxu Sun; Siqi Tan; Silke Thode; Alexander M Tolley; Antoaneta Vladimirova; Jian Yang; Zhiming Zhou; Kurt Jarnagin
Journal:  J Biotechnol       Date:  2005-09-29       Impact factor: 3.307

Review 3.  A review of feature selection techniques in bioinformatics.

Authors:  Yvan Saeys; Iñaki Inza; Pedro Larrañaga
Journal:  Bioinformatics       Date:  2007-08-24       Impact factor: 6.937

4.  Multiplatform single-sample estimates of transcriptional activation.

Authors:  Stephen R Piccolo; Michelle R Withers; Owen E Francis; Andrea H Bild; W Evan Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-15       Impact factor: 11.205

5.  Frozen robust multiarray analysis (fRMA).

Authors:  Matthew N McCall; Benjamin M Bolstad; Rafael A Irizarry
Journal:  Biostatistics       Date:  2010-01-22       Impact factor: 5.899

6.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

Review 7.  Feedback regulation of EGFR signalling: decision making by early and delayed loops.

Authors:  Roi Avraham; Yosef Yarden
Journal:  Nat Rev Mol Cell Biol       Date:  2011-02       Impact factor: 94.444

8.  TopHat: discovering splice junctions with RNA-Seq.

Authors:  Cole Trapnell; Lior Pachter; Steven L Salzberg
Journal:  Bioinformatics       Date:  2009-03-16       Impact factor: 6.937

9.  A comparative study of different machine learning methods on microarray gene expression data.

Authors:  Mehdi Pirooznia; Jack Y Yang; Mary Qu Yang; Youping Deng
Journal:  BMC Genomics       Date:  2008       Impact factor: 3.969

10.  Network quantification of EGFR signaling unveils potential for targeted combination therapy.

Authors:  Bertram Klinger; Anja Sieber; Raphaela Fritsche-Guenther; Franziska Witzel; Leanne Berry; Dirk Schumacher; Yibing Yan; Pawel Durek; Mark Merchant; Reinhold Schäfer; Christine Sers; Nils Blüthgen
Journal:  Mol Syst Biol       Date:  2013       Impact factor: 11.429

View more
  17 in total

Review 1.  Intracellular and intercellular signaling networks in cancer initiation, development and precision anti-cancer therapy: RAS acts as contextual signaling hub.

Authors:  Peter Csermely; Tamás Korcsmáros; Ruth Nussinov
Journal:  Semin Cell Dev Biol       Date:  2016-07-06       Impact factor: 7.727

2.  Glutamine-utilizing transaminases are a metabolic vulnerability of TAZ/YAP-activated cancer cells.

Authors:  Chih-Sheng Yang; Eleni Stampouloglou; Nathan M Kingston; Liye Zhang; Stefano Monti; Xaralabos Varelas
Journal:  EMBO Rep       Date:  2018-04-16       Impact factor: 8.807

Review 3.  The value of genomics in dissecting the RAS-network and in guiding therapeutics for RAS-driven cancers.

Authors:  Gajendra Shrestha; Shelley M MacNeil; Jasmine A McQuerry; David F Jenkins; Sunil Sharma; Andrea H Bild
Journal:  Semin Cell Dev Biol       Date:  2016-06-20       Impact factor: 7.727

4.  β-Catenin/CBP inhibition alters epidermal growth factor receptor fucosylation status in oral squamous cell carcinoma.

Authors:  Kevin Brown Chandler; Khalid A Alamoud; Vanessa L Stahl; Bach-Cuc Nguyen; Vinay K Kartha; Manish V Bais; Kenichi Nomoto; Takashi Owa; Stefano Monti; Maria A Kukuruzinska; Catherine E Costello
Journal:  Mol Omics       Date:  2020-03-23

5.  Integrating microbial and host transcriptomics to characterize asthma-associated microbial communities.

Authors:  Eduardo Castro-Nallar; Ying Shen; Robert J Freishtat; Marcos Pérez-Losada; Solaiappan Manimaran; Gang Liu; W Evan Johnson; Keith A Crandall
Journal:  BMC Med Genomics       Date:  2015-08-16       Impact factor: 3.063

6.  Combating subclonal evolution of resistant cancer phenotypes.

Authors:  Samuel W Brady; Jasmine A McQuerry; Yi Qiao; Stephen R Piccolo; Gajendra Shrestha; David F Jenkins; Ryan M Layer; Brent S Pedersen; Ryan H Miller; Amanda Esch; Sara R Selitsky; Joel S Parker; Layla A Anderson; Brian K Dalley; Rachel E Factor; Chakravarthy B Reddy; Jonathan P Boltax; Dean Y Li; Philip J Moos; Joe W Gray; Laura M Heiser; Saundra S Buys; Adam L Cohen; W Evan Johnson; Aaron R Quinlan; Gabor Marth; Theresa L Werner; Andrea H Bild
Journal:  Nat Commun       Date:  2017-11-01       Impact factor: 14.919

7.  Activity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypes.

Authors:  Mumtahena Rahman; Shelley M MacNeil; David F Jenkins; Gajendra Shrestha; Sydney R Wyatt; Jasmine A McQuerry; Stephen R Piccolo; Laura M Heiser; Joe W Gray; W Evan Johnson; Andrea H Bild
Journal:  Genome Med       Date:  2017-04-26       Impact factor: 11.117

8.  Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer.

Authors:  Vinay K Kartha; Khalid A Alamoud; Khikmet Sadykov; Bach-Cuc Nguyen; Fabrice Laroche; Hui Feng; Jina Lee; Sara I Pai; Xaralabos Varelas; Ann Marie Egloff; Jennifer E Snyder-Cappione; Anna C Belkina; Manish V Bais; Stefano Monti; Maria A Kukuruzinska
Journal:  Genome Med       Date:  2018-07-20       Impact factor: 11.117

9.  Bayesian Sparse Regression Analysis Documents the Diversity of Spinal Inhibitory Interneurons.

Authors:  Mariano I Gabitto; Ari Pakman; Jay B Bikoff; L F Abbott; Thomas M Jessell; Liam Paninski
Journal:  Cell       Date:  2016-03-03       Impact factor: 41.582

10.  Application of the TGx-28.65 transcriptomic biomarker to classify genotoxic and non-genotoxic chemicals in human TK6 cells in the presence of rat liver S9.

Authors:  Carole L Yauk; Julie K Buick; Andrew Williams; Carol D Swartz; Leslie Recio; Heng-Hong Li; Albert J Fornace; Errol M Thomson; Jiri Aubrecht
Journal:  Environ Mol Mutagen       Date:  2016-03-04       Impact factor: 3.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.